Advanced Health Limited to Delist from JSE: Firm Intention for Share Acquisition Signals Strategic Move

  • Advanced Health Limited has announced a firm intention to acquire all issued shares of the company, excluding those held by specific shareholders, through a scheme of arrangement.
  • The proposed offer consideration stands at 80 cents per share, providing shareholders with an opportunity to realize their investments at a price considerably higher than recent trading averages.
  • The company's board of directors believes that delisting from the Johannesburg Stock Exchange (JSE) will better serve Advanced Health's capital raising needs and reduce costs, considering the lack of investment interest in small, illiquid counters.
Advance Health Acquisition

In a significant development, Advanced Health Limited has entered into an agreement with Eenhede Konsultante Eiendoms Beperk (“Eenhede Konsultante”) to make an offer for the acquisition of all issued shares of Advanced Health. The offer, set to be executed through a scheme of arrangement, excludes shares held by VC Family Trust, Carl Grillenberger Family Trust, and Pres Medical Witbank Proprietary Limited. The proposed offer consideration stands at 80 cents per Advanced Health share. If successfully implemented, the scheme will result in Advanced Health’s delisting from the Johannesburg Stock Exchange (JSE).

Since its listing on the JSE in 2014, Advanced Health has strived to attract substantial institutional interest, allowing access to institutional investment funding and utilizing shares as acquisition currency. However, the company has faced challenges in achieving these objectives due to regulatory processes and ongoing compliance costs associated with being listed on the JSE. Furthermore, Advanced Health’s capital-raising efforts have been impeded by the lack of investment interest in small, illiquid counters, as well as the shares’ trading below their underlying net asset value, making any market-value capital raise significantly dilutive for existing shareholders. Recognizing these limitations, the board of directors believes that the costs of maintaining a JSE listing outweigh the benefits and that the company’s capital needs will be better served in an unlisted environment in the medium to long term.

In an effort to provide shareholders with the opportunity to realize their investments in Advanced Health at a price significantly higher than recent trading averages, the board has proposed the scheme of arrangement. The offer consideration of 80 cents per share represents an attractive premium. The board of directors also acknowledges that the company’s smaller asset base and the need to reduce overhead costs no longer justify its continued listing on the JSE, given the current lack of investment interest in small, illiquid counters.

To proceed with the scheme, the requisite majority of Advanced Health shareholders must approve the scheme resolution, and potential court approval may be required. Additionally, the scheme’s implementation is contingent upon the issuance of a compliance certificate by the Takeover Regulation Panel (TRP), which will only be granted once the conditions precedent are met or waived.

At present, Eenhede Konsultante and the Excluded Shareholders collectively hold approximately 71.13% of the issued shares of Advanced Health. Moreover, several shareholders, including Bremer Investments Proprietary Limited, John Biccard, Fiona Biccard, and Rendement Proprietary Limited, have expressed their irrevocable undertakings to vote in favor of the scheme and subsequent delisting.

Visited 1 times, 1 visit(s) today

Stay ahead in the financial world – Sign Up to Rateweb’s essential newsletter for free. Get the latest insights on business trends, tech innovations, and market movements, directly to your inbox. Join our community of savvy readers and never miss an update that could impact your financial decisions.

Do you have a news tip for Rateweb reporters? Please email us at

Related

Personal Financial Tools

Below is a list of tools built to assist South Africans to make the best financial decisions:

Latest

Rateweb

South Africa’s primary source of financial tools and information

Contact Us

admin@rateweb.co.za

Disclaimer

Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.